Priti Kumar

Affiliated with

Research Area

Biography

Priti Kumar has not added Biography.
If you are Priti Kumar and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 9	2019

Other Publications

Article	Year
Targeted delivery of small interfering RNA to human dendritic cells to suppress dengue virus infection and associated proinflammatory cytokine production. Journal of virology\| PubMed ID: 20015996	2010
Targeted disruption of the CCR5 gene in human hematopoietic stem cells stimulated by peptide nucleic acids. Chemistry & biology\| PubMed ID: 21944757	2011
Identification and functional analysis of the primary pantothenate transporter, PfPAT, of the human malaria parasite Plasmodium falciparum. The Journal of biological chemistry\| PubMed ID: 23729665	2013
Site-specific Genome Editing in PBMCs With PLGA Nanoparticle-delivered PNAs Confers HIV-1 Resistance in Humanized Mice. Molecular therapy. Nucleic acids\| PubMed ID: 24253260	2013
Arginine-grafted biodegradable polymer: a versatile transfection reagent for both DNA and siRNA. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 25030923	2014
Effective gene delivery into human stem cells with a cell-targeting Peptide-modified bioreducible polymer. Small (Weinheim an der Bergstrasse, Germany)\| PubMed ID: 25515928	2015
Attachment of cell-binding ligands to arginine-rich cell-penetrating peptides enables cytosolic translocation of complexed siRNA. Chemistry & biology\| PubMed ID: 25544044	2015
Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations. Nature\| PubMed ID: 25561180	2015
Adenovirus-Vectored Broadly Neutralizing Antibodies Directed Against gp120 Prevent Human Immunodeficiency Virus Type 1 Acquisition in Humanized Mice. Human gene therapy\| PubMed ID: 25953321	2015
Cationic cell-penetrating peptides as vehicles for siRNA delivery. Therapeutic delivery\| PubMed ID: 25996046	2015
Retroviruses use CD169-mediated trans-infection of permissive lymphocytes to establish infection. Science (New York, N.Y.)\| PubMed ID: 26429886	2015
Silencing CCR2 in Macrophages Alleviates Adipose Tissue Inflammation and the Associated Metabolic Syndrome in Dietary Obese Mice. Molecular therapy. Nucleic acids\| PubMed ID: 26812653	2016
Trileucine residues in a ligand-CPP-based siRNA delivery platform improve endosomal escape of siRNA. Journal of drug targeting\| PubMed ID: 27820977	2017
Structural and Preclinical Studies of Computationally Designed Non-Nucleoside Reverse Transcriptase Inhibitors for Treating HIV infection. Molecular pharmacology\| PubMed ID: 28167742	2017
Paraoxonase 2 Facilitates Pancreatic Cancer Growth and Metastasis by Stimulating GLUT1-Mediated Glucose Transport. Molecular cell\| PubMed ID: 28803777	2017
From in silico hit to long-acting late-stage preclinical candidate to combat HIV-1 infection. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 29279368	2018
Small Interfering RNA-Mediated Control of Virus Replication in the CNS Is Therapeutic and Enables Natural Immunity to West Nile Virus. Cell host & microbe\| PubMed ID: 29606496	2018
Reply to Pandey et al.: Understanding the efficacy of a potential antiretroviral drug candidate in humanized mouse model of HIV infection. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 30097540	2018
Intranasal delivery of a Fas-blocking peptide attenuates Fas-mediated apoptosis in brain ischemia. Scientific reports\| PubMed ID: 30301943	2018
Structural and pharmacological evaluation of a novel non-nucleoside reverse transcriptase inhibitor as a promising long acting nanoformulation for treating HIV. Antiviral research\| PubMed ID: 31034849	2019